Josh Jennings
Stock Analyst at TD Cowen
(4.44)
# 1,184
Out of 4,675 analysts
1130
Total ratings
49.8%
Success rate
8.2%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintained: Buy | $115 → $135 | $116.64 | +15.74% | 74 | Aug 21, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $12 → $14 | $10.06 | +39.17% | 35 | Aug 19, 2026 | |
| HUMA Humacyte | Maintained: Buy | $1.25 | $0.6422 | +94.64% | 48 | Aug 19, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Hold | $182 | $192.00 | -5.21% | 23 | Aug 17, 2026 | |
| MDWD MediWound | Reiterated: Buy | $25 | $13.21 | +89.25% | 29 | Aug 14, 2026 | |
| ESTA Establishment Labs Holdings | Maintained: Buy | $117 | $72.67 | +61.00% | 53 | Aug 14, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $5 → $3 | $1.42 | +111.27% | 30 | Aug 12, 2026 | |
| SENS Senseonics Holdings | Reiterated: Buy | $15 | $9.71 | +54.48% | 14 | Aug 7, 2026 | |
| OM Outset Medical | Rated: Buy | $10 | $4.21 | +137.53% | 30 | Aug 7, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $120 | $94.77 | +26.62% | 71 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $28 | $21.68 | +29.15% | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $24.20 | +19.83% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $58 | $42.68 | +35.90% | 24 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $29 | $26.34 | +10.10% | 39 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.81 | +77.94% | 37 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $56 | $50.37 | +11.18% | 80 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $92.34 | +2.88% | 41 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $104 | $89.79 | +15.83% | 72 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $119 → $100 | $93.35 | +7.12% | 71 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.98 | +67.04% | 11 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $9.55 | -37.17% | 32 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $5.36 | +179.85% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $270.24 | -7.49% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $20 | $9.48 | +110.97% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $148.16 | +155.80% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 | $329.45 | +32.04% | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.04 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $2.07 | +4,258.35% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $22.32 | -10.39% | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $99 | $100.98 | -1.96% | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.281 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.37 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24.79 | $9.32 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $13 | $0.9509 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $146.12 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $1.39 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.0001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.16 | n/a | 1 | Mar 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $0.000001 | n/a | 1 | Aug 30, 2013 |
Abbott Laboratories
Aug 21, 2026
Maintained: Buy
Price Target: $115 → $135
Current: $116.64
Upside: +15.74%
AVITA Medical
Aug 19, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $10.06
Upside: +39.17%
Humacyte
Aug 19, 2026
Maintained: Buy
Price Target: $1.25
Current: $0.6422
Upside: +94.64%
Becton, Dickinson and Company
Aug 17, 2026
Rated: Hold
Price Target: $182
Current: $192.00
Upside: -5.21%
MediWound
Aug 14, 2026
Reiterated: Buy
Price Target: $25
Current: $13.21
Upside: +89.25%
Establishment Labs Holdings
Aug 14, 2026
Maintained: Buy
Price Target: $117
Current: $72.67
Upside: +61.00%
Stereotaxis
Aug 12, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $1.42
Upside: +111.27%
Senseonics Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $15
Current: $9.71
Upside: +54.48%
Outset Medical
Aug 7, 2026
Rated: Buy
Price Target: $10
Current: $4.21
Upside: +137.53%
TransMedics Group
Aug 5, 2026
Reiterated: Buy
Price Target: $120
Current: $94.77
Upside: +26.62%
Aug 5, 2026
Rated: Buy
Price Target: $34 → $28
Current: $21.68
Upside: +29.15%
Aug 5, 2026
Reiterated: Buy
Price Target: $29
Current: $24.20
Upside: +19.83%
Jul 31, 2026
Reiterated: Buy
Price Target: $55 → $58
Current: $42.68
Upside: +35.90%
Jul 31, 2026
Maintained: Hold
Price Target: $24 → $29
Current: $26.34
Upside: +10.10%
Jul 31, 2026
Reiterated: Buy
Price Target: $5
Current: $2.81
Upside: +77.94%
Jul 30, 2026
Maintained: Buy
Price Target: $61 → $56
Current: $50.37
Upside: +11.18%
Jul 30, 2026
Reiterated: Buy
Price Target: $95
Current: $92.34
Upside: +2.88%
Jul 23, 2026
Rated: Buy
Price Target: $104
Current: $89.79
Upside: +15.83%
Jul 10, 2026
Reiterated: Buy
Price Target: $119 → $100
Current: $93.35
Upside: +7.12%
Jun 29, 2026
Reiterated: Buy
Price Target: $15
Current: $8.98
Upside: +67.04%
Jun 18, 2026
Maintained: Buy
Price Target: $6
Current: $9.55
Upside: -37.17%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $5.36
Upside: +179.85%
Apr 23, 2026
Maintained: Buy
Price Target: $250
Current: $270.24
Upside: -7.49%
Jan 23, 2026
Maintained: Buy
Price Target: $27 → $20
Current: $9.48
Upside: +110.97%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $148.16
Upside: +155.80%
Nov 13, 2025
Maintained: Buy
Price Target: $435
Current: $329.45
Upside: +32.04%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.04
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: $90
Current: $2.07
Upside: +4,258.35%
Nov 6, 2025
Maintained: Buy
Price Target: $20
Current: $22.32
Upside: -10.39%
Nov 5, 2025
Maintained: Hold
Price Target: $104 → $99
Current: $100.98
Upside: -1.96%
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.281
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.37
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $24.79
Current: $9.32
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $15 → $13
Current: $0.9509
Upside: n/a
Oct 29, 2020
Maintained: Buy
Price Target: $80
Current: $146.12
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $1.39
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.0001
Upside: n/a
Mar 18, 2015
Maintained: Buy
Price Target: $9
Current: $1.16
Upside: n/a
Aug 30, 2013
Initiated Coverage: Buy
Price Target: $3.5
Current: $0.000001
Upside: n/a